A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.4c00244 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Nathan Soper und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, New York University, New York, New York 10003, United States. Hauptthemen laut MEDLINE: SARS-CoV-2, Viral Nonstructural Proteins, Antiviral Agents, Drug Repositioning. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, New York University.
Abstract (Originalsprache)
The recent pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlighted a critical need to discover more effective antivirals. While therapeutics for SARS-CoV-2 exist, its nonstructural protein 13 (Nsp13) remains a clinically untapped target. Nsp13 is a helicase responsible for unwinding double-stranded RNA during viral replication and is essential for propagation. Like other helicases, Nsp13 has two active sites: a nucleotide binding site that hydrolyzes nucleoside triphosphates (NTPs) and a nucleic acid binding channel that unwinds double-stranded RNA or DNA. Targeting viral helicases with small molecules, as well as the identification of ligand binding pockets, have been ongoing challenges, partly due to the flexible nature of these proteins. Here, we use a virtual screen to identify ligands of Nsp13 from a collection of clinically used drugs. We find that a known ion channel inhibitor, IOWH-032, inhibits the dual ATPase and helicase activities of SARS-CoV-2 Nsp13 at low micromolar concentrations. Kinetic and binding assays, along with computational and mutational analyses, indicate that IOWH-032 interacts with the RNA binding interface, leading to displacement of nucleic acid substrate, but not bound ATP. Evaluation of IOWH-032 with microbial helicases from other superfamilies reveals that it is selective for coronavirus Nsp13. Furthermore, it remains active against mutants representative of observed SARS-CoV-2 variants. Overall, this work provides a new inhibitor for Nsp13 and provides a rationale for a recent observation that IOWH-032 lowers SARS-CoV-2 viral loads in human cells, setting the stage for the discovery of other potent viral helicase modulators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, New York University, New York, New York 10003, United States.
- Simons Center for Computational Physical Chemistry at New York University, New York, New York 10003, United States.
- NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine, New York, New York 10016, United States.
- High Containment Laboratories, Office of Science and Research, NYU Langone Health, New York, New York 10016, United States.
ORCID-Profile: Chao Yang, Yingkai Zhang, Tania J Lupoli
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- New York University
- U.S. Department of Health and Human Services
- Arnold and Mabel Beckman Foundation
Zitieren
APA
Soper, N., Yardumian, I., Chen, E., Yang, C., Ciervo, S., Oom, A. L., Desvignes, L., Mulligan, M. J., Zhang, Y., & Lupoli, T. J. (2024). A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00244
Vancouver
Soper N, Yardumian I, Chen E, Yang C, Ciervo S, Oom AL, et al. A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00244
BibTeX
@article{Soper2024,
author = {Soper, Nathan and Yardumian, Isabelle and Chen, Eric and Yang, Chao and Ciervo, Samantha and Oom, Aaron L and Desvignes, Ludovic and Mulligan, Mark J and Zhang, Yingkai and Lupoli, Tania J},
title = {A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.4c00244}
}
EUVIMED